HA-1 TCR T-cell immunotherapy

HA-1 T cell receptor (TCR) T-cell therapy · Fred Hutchinson Cancer Center

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for HA-1 TCR T-cell immunotherapy, covering 2025-11-14 to 2025-11-14. Get the full timeline:

Most recent: Clinical Trial Update: HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant [Phase 1]

See pricing